Release Date: 21/04/11 10:23 Summary: ASX Conditions to De-Listing Price Sensitive: No Download Document 51.5KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%